Showing 261-270 of 360 results for "".
- Allergan Aesthetics Completes Soliton Acquisition, Adds Resonic to Portfoliohttps://modernaesthetics.com/news/allergan-aesthetics-completes-soliton-acquisition-adds-resonic-to-portfolio/2473176/It’s official. Allergan Aesthetics, an AbbVie company, completed its acquisition of Soliton, Inc. The addition of Soliton and its technology complements Allergan Aesthetics' portfolio of non-invasive body contouring treatments to now include the RES
- Placental Allograft Technology from MiMedx Shown Beneficial for Mohs Repairshttps://modernaesthetics.com/news/placental-allograft-technology-from-mimedx-shown-beneficial-for-mohs-repairs/2473174/MiMedx Group’s Purion® processed dHACM (Epifix®) placental allografts are associated with a statistically significant lower risk for infection, poor scar cosmesis, scar revision, and additional operation at the index site, when compared to traditional methods of incisional repair po
- Done Deal: RoundTable Healthcare Partners Completes Sale of Revision Skincare and Goodier Cosmetics to Gryphon Investorshttps://modernaesthetics.com/news/done-deal-roundtable-healthcare-partners-completes-sale-of-revision-skincare-and-goodier-cosmetics-to-gryphon-investors/2473172/RoundTable Healthcare Partners completed the previously announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors. Terms of the transaction were not disclosed. Revision Skincare’s portfolio includes Nectifirm, Intellishade, D·E·J
- Galderma to Acquire Alastin Skincarehttps://modernaesthetics.com/news/galderma-to-acquire-alastin-skincare/2473169/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- FDA Clears Sofwave for Eyebrows, Sub-Mental, and Neck Facial Areashttps://modernaesthetics.com/news/fda-clears-sofwave-for-eyebrows-sub-mental-and-neck-facial-areas/2473168/Sofwave is now U.S. Food and Drug Administration (FDA)-cleared for lifting the eyebrow and lifting lax submental tissue and neck tissue in people aged 22 or older. In addition, the Sofwave system featuring the Company's proprietary Superb TM (Synchronous Ultrasound Parallel Be
- Gryphon Investors Signs Deal to Aquire Revision Skincarehttps://modernaesthetics.com/news/gryphon-investors-signs-deal-to-aquire-revision-skincare/2473163/The Middle-market private equity firm Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics, with an anticipating closing date this year. Financial terms of the transaction were not disclosed. Revision Goodier's management team
- Alastin Launches Sensitive Skincare Collectionhttps://modernaesthetics.com/news/alastin-launches-sensitive-skincare-collection/2473154/Alastin’s new sensitive skin collection has launched with three sensitive skincare products: Ultra Calm Cleansing Cream, Ultra Light Moisturizer with TriHex Technology® and SilkSHIELD All-Mineral Sunscreen SPF 30 with TriHex Technology®. The collection includes ultra-calming, restor
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s
- Galderma's Restylane Turns 25!https://modernaesthetics.com/news/galdermas-restylane-turns-25/2473147/Galderma’s Restylane is celebrating 25 years on the market. Since launching in Europe in 1996, Restylane has celebrated many milestones across the globe. This includes the first approval for use by the U.S. Food and Drug Administration (FDA) in 2003 and in China by the Nation
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc